PARP9, originally known as B-aggressive lymphoma-1 (BAL1), was identified as a risk-associated gene in aggressive diffuse large B-cell lymphoma (DLBCL) (Aguiar et al., 2000, 2005). This evidence concerns the gene PARP9 and diffuse large B-cell lymphoma.